correct massive dilution for current holders, the new backers will be the only winners here, probably more like $600 a share mate
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025